| Literature DB >> 22342549 |
Ting Lei1, Kam-Leung Siu, Kin-Hang Kok, Kwok-Hung Chan, Eric Y T Chan, Ivan F N Hung, Kelvin K W To, Patrick C K Li, Jie Zhou, Bo-Jian Zheng, Kwok-Yung Yuen, Ming Wang, Dong-Yan Jin.
Abstract
Recipients of influenza A (H1N1) vaccine in 1976 had an increased risk for the neurologic disorder Guillain-Barré syndrome (GBS). Anti-ganglioside antibodies, which might be associated with the development of GBS, were previously reported to be induced in mice immunized with an H1N1 vaccine of 1976 or another influenza vaccine. In this study we analyzed anti-ganglioside antibodies in human subjects infected with or vaccinated against 2009 pandemic H1N1, including eight patients diagnosed to have post-vaccination GBS. Antibodies against GM1 or another ganglioside were not detected in any subject or in vaccinated mice. Our results did not support the induction of anti-ganglioside antibodies by influenza viruses or vaccines. Copyright ÂEntities:
Mesh:
Substances:
Year: 2012 PMID: 22342549 DOI: 10.1016/j.vaccine.2012.02.009
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641